Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blood-brain barrier
Biotech
Novartis inks $175M option deal for Sironax’s BBB tech
If Novartis decides to buy the platform, Sironax will have the chance to make up to $175 million in upfront and near-term payments.
Gabrielle Masson
Jul 9, 2025 10:29am
GSK pens $2.5B pact for ABL's blood-brain barrier-bypassing tech
Apr 7, 2025 7:00am
Astellas pays Sangamo $20M to boost neurological gene therapies
Dec 19, 2024 7:13am
BMS pays Leqembi originator $100M for Alzheimer's prospects
Dec 19, 2024 5:23am
AbbVie inks $1.4B Aliada buyout to land ex-J&J Alzheimer's drug
Oct 28, 2024 10:00am
Denali reports new method to get ASOs across blood-brain barrier
Aug 14, 2024 2:00pm
